Donald Trump Strikes New Drug Price Deal as Democrats Eye Midterm Gains
Trump says all 50 states have joined his Medicaid drug-pricing plan as Democrats seek to keep healthcare central in the midterms.
President Donald Trump has announced a new Medicaid drug pricing model that will apply to all 50 states, aiming to lower the cost of certain prescription medicines through an international reference-pricing system. The initiative, known as the GENEROUS model, could potentially reduce pharmaceutical spending for state and federal Medicaid programs through new manufacturer rebates.
This development is seen as a major healthcare policy achievement for Republicans, as Democrats look to address healthcare affordability, Medicare, and prescription drug costs in the upcoming midterm elections.
Brief written by urgent.news from Newsweek's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
